Tercica, Inc. Stock Doubles on Acquisition News
Jun 5th, 2008 | By J. Christoph Amberger | Category: Stock Market InvestingBrisbane-based growth hormone company Tercica, Inc. (TRCA:NASDAQ) will be acquired by French drugmaker Ipsen SA in a stock deal valued at more than $400 million.
